Works matching IS 22250719 AND DT 2025 AND VI 13 AND IP 5

Results: 10

Inhibition of Cyclooxygenase-2 Upregulates the Nuclear Factor Erythroid 2-related Factor 2 Signaling Pathway to Mitigate Hepatocyte Ferroptosis in Chronic Liver Injury.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 409, doi. 10.14218/JCTH.2024.00440

By:

Zhu Yang;
Yang Tai;
Tian Lan;
Chong Zhao;
Jin-Hang Gao;
Cheng-Wei Tang;
Huan Tong

Publication type:

Article

Mitochondrial Membrane Potential of CD8<sup>+</sup> T Cells Predicts Bacterial Infection and Rapid Development of Acute-onchronic Liver Failure in Cirrhotic Patients.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 395, doi. 10.14218/JCTH.2024.00452

By:

Xixuan Wang;
Shuling Chen;
Jing Fan;
Yuxiang Gong;
Hongli Liu;
Lili Wang;
Xiaoning Feng;
Hui Zhou;
Wenquan Zeng;
Changhua Yi;
Caiyun Zhang;
Qingfang Xiong;
Hao Ren;
Yongfeng Yang

Publication type:

Article

FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-ö Signaling Pathway.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 385, doi. 10.14218/JCTH.2025.00007

By:

Lin Zhang;
Li Gan;
Yuru Lin;
Zhechuan Mei;
Shengtao Liao

Publication type:

Article

GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 374, doi. 10.14218/JCTH.2024.00386

By:

Yani Wu;
Yingnan Yang;
Youju Zhang;
Qiuran Xu;
Dongsheng Huang;
Kangsheng Tu

Publication type:

Article

Corrigendum: Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14.

Published in:: Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 440, doi. 10.14218/JCTH.2024.00414C
Publication type:: Article

Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 434, doi. 10.14218/JCTH.2025.00051

By:

Tampaki, Maria;
Cholongitas, Evangelos

Publication type:

Article

Non-variceal Extrahepatic Portosystemic Shunts: A Review of Pathogenesis, Diagnosis, and Treatment.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 425, doi. 10.14218/JCTH.2024.00315

By:

Anastasio, Nicole M.;
Wu, George Y.

Publication type:

Article

Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 418, doi. 10.14218/JCTH.2024.00499

By:

Chencheng Xie;
Singal, Ashwani K.

Publication type:

Article

Analysis of the Disease Spectrum Characteristics of Inherited Metabolic Liver Diseases in Two Hepatology Specialist Hospitals in Beijing over the Past 20 Years.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 367, doi. 10.14218/JCTH.2025.00030

By:

Wei Hou;
Yuanzhi Huang;
Tang Shang;
Zheng Wang;
Wei Zhang;
Kefi Wang;
Yinjie Gao;
Min Zhang;
Sujun Zheng

Publication type:

Article

Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial.

Published in:

Journal of Clinical & Translational Hepatology, 2025, v. 13, n. 5, p. 361, doi. 10.14218/JCTH.2024.00472

By:

Xiaobo Cai;
Yin Qu;
Wen Xie;
Yanbin Wang;
Mengyu Zhao;
Ling Zhang;
Ying Luo;
Ping Yin;
Jun Cheng;
Lungen Lu

Publication type:

Article